MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platforms

Table 2 Experimental design of four breast cancer cohorts including 4 cancer subtypes: Basal, HER2, Luminal A (LumA) and Luminal B (LumB)

Experiment	Platform	Basal	Her2	LumA	LumB
METABRIC Discovery	Illumina HT-12 v3	118	87	466	268
METABRIC Validation	Illumina HT-12 v3	213	153	255	224
TCGA RNA-seq	illumina HiSeq 2000	188	80	549	213
Total training set	2 platforms	519	320	1270	705
TCGA microarray	Agilent custom 244K	57	31	99	67
Total test set	1 platform	57	31	99	67

ISSN: 1471-2105